|
CCDC88A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.73040470841102E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.60780000038707E-07 |
| Normal-vs-Stage2 |
1.556660E-03 |
| Normal-vs-Stage3 |
4.35899999999823E-05 |
| Normal-vs-Stage4 |
4.373700E-02 |
| Stage1-vs-Stage2 |
1.327030E-01 |
| Stage1-vs-Stage3 |
1.372010E-01 |
| Stage1-vs-Stage4 |
2.433600E-01 |
| Stage2-vs-Stage3 |
8.460000E-01 |
| Stage2-vs-Stage4 |
9.728800E-01 |
| Stage3-vs-Stage4 |
8.467400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.39779990202283E-10 |
| Normal-vs-AfricanAmerican |
1.008080E-04 |
| Normal-vs-Asian |
3.491500E-02 |
| Caucasian-vs-AfricanAmerican |
9.391000E-01 |
| Caucasian-vs-Asian |
2.606400E-01 |
| AfricanAmerican-vs-Asian |
3.631400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.59569999938591E-08 |
| Normal-vs-Female |
1.43669964813853E-10 |
| Male-vs-Female |
6.042200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.441600E-04 |
| Normal-vs-Extreme_Weight |
2.06429999999314E-05 |
| Normal-vs-Obese |
1.2363000001514E-07 |
| Normal-vs-Extreme_Obese |
1.749150E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.100400E-01 |
| Normal_Weight-vs-Obese |
2.657800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.580800E-01 |
| Extreme_Weight-vs-Obese |
1.085980E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.195400E-01 |
| Obese-vs-Extreme_Obese |
2.148600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.8213499999975E-05 |
| Normal-vs-Age(41-60Yrs) |
4.38880043418521E-11 |
| Normal-vs-Age(61-80Yrs) |
1.63672999999864E-05 |
| Normal-vs-Age(81-100Yrs) |
4.319800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.884000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.633540E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.001800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.960400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.574400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.995200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.51610002330216E-09 |
| Normal-VS-Type2 PRCC |
9.617500E-04 |
| Normal-VS-KIRP CIMP |
1.446090E-04 |
| Normal-VS-Unclassified PRCC |
4.1962000000284E-06 |
| Type1 PRCC-VS-Type2 PRCC |
1.904370E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.01890000000638E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
8.563500E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.844930E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.436700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.396600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.219800E-04 |
| Normal-vs-N1 |
1.448950E-04 |
| Normal-vs-N2 |
2.09780000004489E-06 |
| N0-vs-N1 |
2.785700E-02 |
| N0-vs-N2 |
1.324200E-01 |
| N1-vs-N2 |
9.780400E-01 |
|
|
